Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial
scientific article
Author/s
author: Hagop Kantarjian, Norbert Ifrah, Giovanni Martinelli, Jorge Eduardo Cortes, Hartmut Döhner, Hervé Dombret, Elihu Estey, Stephen A. Strickland, Mark J Levis, Jessica K Altman, Philippe Rousselot, Eunice S Wang, Tibor Kovacsovics, Alexander E Perl, Guy Gammon, Denise Trone, Nigel Russell
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.